Synovus Financial Corp.
Synovus Financial Corp. (SNV) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Synovus Financial Corp. (SNV), covering cash flow, earnings, and balance sheets.
Synovus Financial Corp. (SNV) Income Statement & Financial Overview
Analyze Synovus Financial Corp.’s SNV earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $881.03M | $924.72M | $925.79M | $672.39M |
Cost of Revenue | $323.30M | $377.003M | $393.20M | $392.65M |
Gross Profit | $557.73M | $547.71M | $532.59M | $279.74M |
Gross Profit Ratio | $0.63 | $0.59 | $0.58 | $0.42 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $194.05M | $192.95M | $192.20M | $185.90M |
Operating Expenses | $305.83M | $309.31M | $304.99M | $301.80M |
Total Costs & Expenses | $629.14M | $686.31M | $698.19M | $694.45M |
Interest Income | $766.76M | $799.13M | $810.51M | $801.24M |
Interest Expense | $312.38M | $344.14M | $369.77M | $366.24M |
Depreciation & Amortization | $11.54M | $12.86M | $13.34M | $16.36M |
EBITDA | $263.44M | $251.26M | $240.93M | -$5.70M |
EBITDA Ratio | $0.30 | $0.27 | $0.26 | -$0.008 |
Operating Income | $251.90M | $238.40M | $227.60M | -$22.06M |
Operating Income Ratio | $0.29 | $0.26 | $0.25 | -$0.03 |
Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
Income Before Tax | $251.90M | $238.40M | $227.60M | -$22.06M |
Income Before Tax Ratio | $0.29 | $0.26 | $0.25 | -$0.03 |
Income Tax Expense | $57.02M | $49.03M | $46.91M | -$7.38M |
Net Income | $195.01M | $190.43M | $181.56M | -$14.03M |
Net Income Ratio | $0.22 | $0.21 | $0.20 | -$0.02 |
EPS | $1.31 | $1.26 | $1.19 | -$0.16 |
Diluted EPS | $1.30 | $1.25 | $1.18 | -$0.16 |
Weighted Avg Shares Outstanding | $140.68M | $144.16M | $143.14M | $145.56M |
Weighted Avg Shares Outstanding (Diluted) | $141.78M | $145.00M | $143.98M | $145.56M |
Over the past four quarters, Synovus Financial Corp. demonstrated steady revenue growth, increasing from $672.39M in Q2 2024 to $881.03M in Q1 2025. Operating income reached $251.90M in Q1 2025, maintaining a consistent 29% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $263.44M, reflecting operational efficiency. Net income rose to $195.01M, with EPS at $1.31. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan